Coeptis Therapeutics Holdings Inc

COEP
0,3068
-0,0302 (-8,96%)
Ultimo aggiornamento: 16:38:59
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/5/202414:47PRNUSCoeptis Therapeutics to Present its Universal Allogeneic..
02/5/202414:47PRNUSCoeptis Therapeutics Announces Poster Data Presentation at..
02/4/202414:47PRNUSCoeptis Therapeutics Congratulates Alexander Deiters,..
26/2/202415:00PRNUSCoeptis Therapeutics Adds Autoimmune Indications to..
07/2/202413:30PRNUSCoeptis Therapeutics to Pursue Phase 2 Program Using..
04/1/202413:30PRNUSCoeptis Therapeutics President and CEO Issues Letter to..
31/10/202314:01PRNUSCoeptis Therapeutics Announces Research Demonstrating the..
24/10/202314:30PRNUSCoeptis Therapeutics Announces $2 Million Private Placement
11/10/202313:30PRNUSCoeptis Therapeutics Expands License Agreement with..
09/10/202315:15PRNUSCoeptis Therapeutics to Participate in Panel at the..
04/10/202313:30PRNUSCoeptis Therapeutics Announces Research Involving SNAP-CAR..
27/9/202313:30PRNUSCoeptis Therapeutics to Present at the 2023 Cell & Gene..
14/9/202313:30PRNUSCoeptis Therapeutics Provides Safety and Dosing Update from..
11/9/202313:30PRNUSCoeptis Therapeutics Announces Deverra Therapeutics Has..
30/8/202319:00PRNUSCoeptis Therapeutics Appoints Colleen Delaney, MD, as Chief..
17/8/202313:30PRNUSCoeptis Therapeutics Completes Exclusive License for..
01/8/202314:00PRNUSCoeptis Therapeutics Files FDA 513(g) Submission for CD38 In..
16/6/202322:00PRNUSCoeptis Therapeutics Holdings, Inc. Announces Closing of..
14/6/202315:28PRNUSCoeptis Therapeutics Holdings, Inc. Announces Pricing of..
09/6/202313:00PRNUSCoeptis Therapeutics Receives Approval to Transfer to The..
Apertura: 0,324 Min: 0,2769 Max: 0,3297
Chiusura: 0,337

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network